Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Halperin

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
The American Journal of Cardiology|July 1, 1984
Myopotential interference with DDD pacemakers: endocardial electrographic telemetry in the diagnosis of pacemaker-related arrhythmiasJ L Halperin, J L Camuñas, E H Stern, et al.
Genes, Chromosomes & Cancer|June 22, 2000
An Alu-mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10E M Rohlfs, N Puget, M L Graham, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 10, 1999
Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study)R W Asinger, J Koehler, L A Pearce, et al.
Journal of Thrombosis and Haemostasis : JTH|June 19, 2013
Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approachJ M Kittelson, A C Spyropoulos, J L Halperin, et al.
Journal of Thrombosis and Haemostasis : JTH|February 5, 2010
Comparative performance of gene-based warfarin dosing algorithms in a multiethnic populationS A Lubitz, S A Scott, E B Rothlauf, et al.
American Heart Journal|February 27, 1999
Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study. Stroke Prevention in Atrial Fibrillation InvestigatorsH C Dittrich, L A Pearce, R W Asinger, et al.
Journal of Clinical Pharmacology|March 27, 2014
Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AFI G Girgis, M R Patel, G R Peters, et al.
The New England Journal of Medicine|May 11, 2001
Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillationA L Klein, R A Grimm, R D Murray, et al.
European Heart Journal|October 17, 2001
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and ElectrophysiologyV Fuster, L E Rydén, R W Asinger, et al.
Journal of Thrombosis and Haemostasis : JTH|June 30, 2015
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findingsN A Goldenberg, T Abshire, P J Blatchford, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
The American Journal of Cardiology|July 1, 1984
Myopotential interference with DDD pacemakers: endocardial electrographic telemetry in the diagnosis of pacemaker-related arrhythmiasJ L Halperin, J L Camuñas, E H Stern, et al.
Genes, Chromosomes & Cancer|June 22, 2000
An Alu-mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10E M Rohlfs, N Puget, M L Graham, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 10, 1999
Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study)R W Asinger, J Koehler, L A Pearce, et al.
Journal of Thrombosis and Haemostasis : JTH|June 19, 2013
Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approachJ M Kittelson, A C Spyropoulos, J L Halperin, et al.
Journal of Thrombosis and Haemostasis : JTH|February 5, 2010
Comparative performance of gene-based warfarin dosing algorithms in a multiethnic populationS A Lubitz, S A Scott, E B Rothlauf, et al.
American Heart Journal|February 27, 1999
Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study. Stroke Prevention in Atrial Fibrillation InvestigatorsH C Dittrich, L A Pearce, R W Asinger, et al.
Journal of Clinical Pharmacology|March 27, 2014
Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AFI G Girgis, M R Patel, G R Peters, et al.
The New England Journal of Medicine|May 11, 2001
Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillationA L Klein, R A Grimm, R D Murray, et al.
European Heart Journal|October 17, 2001
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and ElectrophysiologyV Fuster, L E Rydén, R W Asinger, et al.
Journal of Thrombosis and Haemostasis : JTH|June 30, 2015
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findingsN A Goldenberg, T Abshire, P J Blatchford, et al.
Pageof 8